SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-014499
Filing Date
2022-03-23
Accepted
2022-03-23 16:29:16
Documents
1
Period of Report
2022-03-21

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5958
  Complete submission text file 0001213900-22-014499.txt   7294
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Issuer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 10609 RIVER OAKS LANE POTOMAC MD 20859
Business Address
Ganjei James Kelly (Reporting) CIK: 0001767300 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38793 | Film No.: 22763533